When looking at the second well-known CML-specific antigen PR-1, it was demonstrated that patients entering cytogenetic remission through administration of IFN-alpha also had a re-emergence of high-affinity antigen-specific CD8 cells with potent cytolytic activity in vitro [31]. This evidence concerns the gene TMEM37 and chronic myelogenous leukemia, BCR-ABL1 positive.